Emyria Limited

Emyria Limited - ROEverified

EMD.AX

Price:

$0.041

Market Cap:

$23.48M

Emyria Limited is a biotechnology firm currently in the clinical stage, dedicated to creating therapies for medical conditions that lack effective treatments. The company's work primarily involves the development of cannabinoid-derived pharmaceuticals, alongside an initiative for discovering new MDMA-based drugs. Among its pipeline, EMD-RX5 is being explored for psychological distress and irritable bowel syndrome, while EMD-RX7 targets a variety of medical conditions. Established in 2018 and based in Leederville, Australia, the company adopted its current name, Emyria Limited, in September 2020, having previously operated as Emerald Clinics Limited.

Industry

Medical - Healthcare Information Services

IPO Date

2020-02-11

Stock Exchange

ASX

Ticker

EMD.AX

The ROE as of October 2026 (TTM) for Emyria Limited (EMD.AX) is -58.38%

According to Emyria Limited’s latest financial reports and current stock price. The company's current ROE is -58.38%. This represents a change of 77.88% compared to the average of -32.82% of the last 4 quarters.

Emyria Limited (EMD.AX) Historical ROE (quarterly & annually)

How has EMD.AX ROE performed in the past?

The mean historical ROE of Emyria Limited over the last ten years is -170.92%. The current -58.38% ROE has changed -65.84% with respect to the historical average. Over the past ten years (40 quarters), EMD.AX's ROE was at its highest in in the December 2019 quarter at 118.36%. The ROE was at its lowest in in the June 2019 quarter at -1362.89%.

Quarterly (TTM)
Annual

Average

-170.92%

Median

-75.53%

Minimum

-537.08%

Maximum

-2.29%

Emyria Limited (EMD.AX) ROE by Quarter and Year

Discovering the peaks and valleys of Emyria Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 23.34%

Maximum Annual ROE = -2.29%

Minimum Annual Increase = -87.46%

Minimum Annual ROE = -537.08%

Quarterly (TTM)
Annual
YearROEChange
2026-69.12%16.69%
2025-59.24%-87.46%
2024-472.33%525.37%
2023-75.53%-34.84%
2022-115.91%69.59%
2021-68.35%-50.64%
2020-138.47%-74.22%
2019-537.08%23.34%

Emyria Limited (EMD.AX) Average ROE

How has EMD.AX ROE performed in the past?

The current ROE of Emyria Limited (EMD.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-200.23%

5-year avg

-158.43%

10-year avg

-170.92%

Emyria Limited (EMD.AX) ROE vs. Peers

How is EMD.AX’s ROE compared to its peers?

Emyria Limited’s ROE is greater than INOVIQ Ltd (-36.48%), greater than Nova Eye Medical Limited (-28.79%), greater than Argenica Therapeutics Ltd (-29.22%), greater than Little Green Pharma Ltd (-1.67%), greater than Vitura Health Limited (-9.80%), greater than Microba Life Sciences Limited (-75.96%), greater than BCAL Diagnostics Limited (-881.94%), greater than Next Science Limited (-130.18%), less than Doctor Care Anywhere Group PLC (90.90%), greater than AnteoTech Limited (-71.28%),

Build a custom stock screener for Emyria Limited (EMD.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emyria Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emyria Limited (EMD.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emyria Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Emyria Limited's ROE?

How is the ROE calculated for Emyria Limited (EMD.AX)?

What is the highest ROE for Emyria Limited (EMD.AX)?

What is the 3-year average ROE for Emyria Limited (EMD.AX)?

What is the 5-year average ROE for Emyria Limited (EMD.AX)?

How does the current ROE for Emyria Limited (EMD.AX) compare to its historical average?